| Document |
Document Title |
|
WO/2005/100373A2 |
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and au...
|
|
WO/2005/097286A1 |
Chromatographic separation equipment characterized in that two pumps are employed for controlling chromatographic separation that combines a first process for supplying at least one of stock solution and eluent into a circulation system ...
|
|
WO/2005/094611A1 |
The present invention provides fat replacement compositions imparting advantageous organoleptic properties to reduced calorie foodstuffs. The fat replacement compositions generally include a mixture of tagatose and at least one indigesti...
|
|
WO/2005/092931A1 |
A sugar donor having a glucuronic acid or iduronic acid derivative at the reducing end and in which a leaving group is added to the reducing end hydroxyl group to be glycosylated and the other hydroxyl groups and the carboxyl groups are ...
|
|
WO/2005/089776A1 |
The present invention provides algin oligosaccharides having polymerized degree of 2-22 and the derivatives thereof, such algin oligosaccharides are made of mannuronic acid bonded by ∝-1,4 glycosidic bond. The derivatives which the red...
|
|
WO/2005/090411A1 |
The invention provides a process for preparing heparin products with a reduced content of glycoserine. A method for detecting glycoserine in preparations of heparin is also provided.
|
|
WO/2005/090376A1 |
Disclosed herein is a process for producing chlorinated sucrose, mainly 1',6'-Dichloro-1',6'-Dideoxy-β-D-Fructo-Furanosyl-4-Chloro-
4-Deoxy-&agr -D-Galactopyranoside by chlorination of 6-acetyl sucrose in the presence of a solvent such ...
|
|
WO/2005/090375A1 |
The invention relates to a method for enriching trehalose from solutions, wherein the enrichment is performed with the aid of an adsorbent. The invention is characterized in that the adsorbent is an alumosilicate. The alumosilicate is pr...
|
|
WO/2005/086612A2 |
Disclosed are novel conjugates that include fluorinated carbohydrate molecules and methods for synthesizing the conjugates. The fluorinated carbohydrate molecule may include a radioisotope. The method of synthesizing the conjugate is use...
|
|
WO/2005/085263A1 |
The invention relates to a molecular spacer, to a method of fixing a molecular unit to a solid support and to the use of said spacer on analysis chips with molecules or biomolecules. According to the invention, the spacer has formula (I)...
|
|
WO/2005/085264A1 |
The invention relates to compounds which are polysufated oligosaccharide derivatives having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; methods for the preparation of the compounds;...
|
|
WO/2005/080489A1 |
The present invention discloses a solution of metal-polymer chelate(s) and applications thereof. The solution is prepared as follows: the carbohydrate ,and/or the polymer having hydroxyl, and/or the polymer having hydroxyl , amino and/or...
|
|
WO/2005/078140A1 |
A process for producing a monosaccharide from biomass, comprising the first step (3) of conducting pretreatment of biomass as a raw material in 65 to 85 mass% sulfuric acid at 30 to 70°C and the second step (4) of saccharifying the prod...
|
|
WO/2005/067548A2 |
D-Ribose is administered before and after general anaesthesia to reduce the time to recover from the effects of general anaesthesia. Preferably, pyrogen-free D-Ribose is administered intravenously during general anaesthesia and the inter...
|
|
WO/2005/066192A1 |
The invention relates to a ketose sugar preparation method. According to the invention, a solution or a suspension in water of aldose-type sugar is reacted with potassium aluminate in order to convert the aldose into ketose by means of a...
|
|
WO/2005/060977A1 |
The present invention relates to the use of known and novel compounds as inhibitors of UDP-G1cNAc:Galβ1,3GalNAc-R (GlcNAc to GalNAc) β1,6-N- acetylglucosaminyl transferase (core 2 β1,6 N-acetylaminotransferase, core 2 GlcNAc-T -EC 2.4...
|
|
WO/2005/058932A1 |
The invention aims at finding remedies for dry eye or corneal and conjunctival epitheliopathies caused by dry eye. Eye drops containing mannose exert excellent ameliorative effects on dry eye or corneal and conjunctival epitheliopathies ...
|
|
WO/2005/054264A2 |
Compounds and methods are provided for modulating in vivo and in vivo processes mediated by selectin biniding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g. inhibi...
|
|
WO/2005/052008A1 |
A β-glucan derivative comprising a β-glucan residue of three or more glucose residues and, chemically bonded to the β-glucan residue, a nonreducing sugar residue.
|
|
WO/2005/052195A1 |
A method of preparing L-arabinose from sugar beet pulp comprising the steps of: (a) treatment of a sugar beet pulp with aqueous alkali to provide a crude aqueous araban extract; (b) treatment of the crude araban extract with a precipitat...
|
|
WO/2005/049046A1 |
It is intended to provide a hypotensive drug which is highly safe and can be obtained at a low cost. Namely, a hypotensive agent which comprises one or more hexoses and contains an oligosaccharide having one or more 1-6 bonds.
|
|
WO/2005/044833A1 |
A process for producing levoglucosan with high yield while suppressing any secondary thermal decomposition. There is provided a process for producing levoglucosan, characterized in that a water soluble saccharide is subjected to intramol...
|
|
WO/2005/041983A1 |
The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40, said medicament being preferably intended to regulate inflammatory...
|
|
WO/2005/042553A1 |
The invention relates to a method of preparing oligorhamnosides, comprising a one-pot reaction in acetonitrile without any rhamnose protection or deprotection reaction. The invention also relates to a composition comprising a mixture of ...
|
|
WO/2005/026219A1 |
The invention relates to polymers graft by chemical synthetic or natural saccharidic molecules and to a method for the preparation thereof. Said polymers make it possible to fix the saccharidic molecules to a solid support for screening ...
|
|
WO/2005/021475A1 |
Disclosed a method of producing sugar alcohols through the hydrogenation of sugars using a catalyst in which ruthenium is supported on a carrier comprising silica, zirconia, or a mixture thereof. The method includes hydrogenating sugar u...
|
|
WO/2005/021564A1 |
It is intended to provide a novel nonreducing saccharide having glucose as its constituting sugar to thereby broaden the range of selecting nonreducing saccharides. It is also intended to provide a novel enzyme for synthesizing the above...
|
|
WO/2005/016974A1 |
Derivatives are synthesised of starting materials, usually polysaccharides, having sialic acid at the reducing terminal end, in which the reducing terminal unit is transformed into an aldehyde group. Where the polysaccharide has a sialic...
|
|
WO/2005/016949A2 |
Sialic acid reducing units are passivated, for instance by reduction, or by reductive amination or capping. The process is useful for producing chemically inert sialic acid compounds especially polysialic acids for instance of use as exc...
|
|
WO/2005/007171A1 |
A accelerator for mineral absorption and a composition for mineral absorption acceleration which contains the accelerator. The accelerator for mineral absorption comprises a cyclic tetrasaccharide and/or a glucide derivative thereof as a...
|
|
WO/2005/007664A1 |
A novel glucide which is a 3-&agr -glycosyl &agr ,&agr -trehalose compound having the 3-&agr -glucosyl &agr ,&agr -trehalose structure represented by the chemical formula (1) in the molecule.
|
|
WO/2005/003329A1 |
Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of oligosaccharidcs may be incorporated into numerous fo...
|
|
WO/2005/000210A2 |
A process for preparing parenteral iron-saccharidic complexes, and the complexes produced, comprising: (1) providing an aqueous solution or dispersion including (i) Fe (III) and (OH)- ions and (ii) at least one saccharide, to form a reac...
|
|
WO/2005/000907A1 |
The invention provides sulfo-protected polysaccharides and methods for preparing sulfo-protected polysaccharides, as well as intermediate compounds useful in such methods. A saccharide having a hydroxyl or amine protected with a haloalky...
|
|
WO/2005/000861A1 |
It is intended to provide a method of chemically synthesizing at a high efficiency a biomolecule typified by a nucleotide (nucleic acid), a peptide (protein) or a sugar chain. Namely, a method of solid phase synthesis of a sugar chain ch...
|
|
WO/2004/111067A1 |
An association product of &agr -glycosyl&agr ,&agr -treholose with an ionic metal compound; a method for preparing the association product; and a use thereof. The above association product is a preparation of an ionic metal compound whic...
|
|
WO/2004/108739A2 |
The invention relates to a process for the production of crystalline xylose, from sugar cane bagasse, which xylose consists of microcrystals having a well-defined morphology and a narrow granulometric range, a further object of the inven...
|
|
WO/2004/108742A1 |
A method for characterising the structure or sub-structure of a glycan or glycan derivative, experimentally derives the mass of an unidentified glycan molecule and compares the mass of the unidentified glycan molecule with identified and...
|
|
WO/2004/104016A1 |
A process for the preparation of 4, 1', 6'- trichoro-4, 1', 6'-trideoxygalactosucrose is characterized by that raw material sucrose is added into N,N-dimethylformamide, and transesterification is conducted between sucrose and ethyl aceta...
|
|
WO/2004/099429A1 |
A process for producing an oligosaccharide with a high degree of polymerization from a polysaccharide, which comprises hydrolyzing a polysaccharide, such as starch, with a hydrolase which cleaves the linkage between the sugar molecules c...
|
|
WO/2004/089964A1 |
A lipid-regulating agent and a composition for lipid control which contains the lipid-regulating agent. The lipid-regulating agent comprises as an active ingredient a cyclic tetrasaccharide and/or a glucide derivative thereof.
|
|
WO/2004/084644A1 |
Disclosed is a method and a product of a chicory root product for reducing taint in animals, said method comprising feeding to an animal a chicory root product during at least one day prior to slaughtering the animal. By feeding animals ...
|
|
WO/2004/083258A2 |
The present invention provides branched water-soluble polymers that allow two or more water-soluble polymers to be conjugated to another species. The branched polymers provide access to therapeutic agents that are conjugated at a single ...
|
|
WO/2004/082576A2 |
The present invention relates to direct compressible crystalline or semi-crystalline trehalose solids having a crystal form selected from the group consisting of trehalose dihydrate and mixtures of trehalose dihydrate and anhydrous treha...
|
|
WO/2004/083226A1 |
The present invention provides an anti-microbial composition comprising microthecin or a derivative thereof as an active anti-microbial component, and the microorganism is selected from Candida albicans, Aspergillus fumigentus, E. coli, ...
|
|
WO/2004/081022A2 |
Methods for the production of substrate, tuber, and grain compositions containing isomalto-oligosaccharides are described. The methods comprise (a) contacting a substrate, tuber or grain containing ungelatinized starch with a maltogenic ...
|
|
WO/2004/078989A1 |
Crystal of highly purified difructose-dianhydride III (di-D-fructofranose-1,2';2,3'dianhydride, hereinafter referred to as DFA III) is produced by a process comprising providing a DFA III purified solution containing DFA III of 90% or hi...
|
|
WO/2004/078966A1 |
A process for constructing a transgenic plant having fructooligosaccharide accumulated therein which comprises the step of transforming a plant with a gene construct containing a gene encoding β-fructofranosidase capable of converting s...
|
|
WO/2004/074303A2 |
The present invention provides methods for preparing LPS antagonist lipodisaccharide B1287 and stereoisomers thereof, which compounds are useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia...
|
|
WO/2004/074496A1 |
The present invention relates to a process for the production of a novel oligosaccharide, the process comprising combining a substrate with lactobacillus alpha-galactosidase enzyme. The invention also relates to the oligosaccharide itsel...
|
